NCT00849992

Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy

Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: Norwegian University of Science and Technology · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.

Detailed description

Randomized study comparing imiquimod 5% with photodynamic therapy for actinic cheilitis. Histological, efficacy, epidemiological and clinical data will be collected.

Conditions

• Actinic Cheilitis

Interventions

Type	Name	Description
DRUG	Imiquimod 5%	Imiquimod 5% cream used three days a week for 4 weeks
PROCEDURE	Photodynamic therapy	Photodynamic therapy involves applying Metvix cream to the affected area followed by illumination. It will be done twice during the study at a 2 week interval.

Timeline

• Start date: 2009-03-01
• Primary completion: 2013-03-01
• Completion: 2013-11-01
• First posted: 2009-02-24
• Last updated: 2017-05-15

Locations

1 site across 1 country: Norway